{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T11:56:39Z","timestamp":1792324599228,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"crossref","award":["FAR 2016\/2017"],"award-info":[{"award-number":["FAR 2016\/2017"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jpba.2018.06.060","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T09:27:01Z","timestamp":1530350821000},"page":"192-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride in rat plasma by using high performance liquid chromatography-diode array detector"],"prefix":"10.1016","volume":"159","author":[{"given":"L.","family":"Malatesta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5223-9879","authenticated-orcid":false,"given":"D.","family":"Paolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7429-5591","authenticated-orcid":false,"given":"F.","family":"Cilurzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8927-0116","authenticated-orcid":false,"given":"A.","family":"Di Tullio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8062-817X","authenticated-orcid":false,"given":"M.","family":"Fresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Celia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Di Marzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0840-825X","authenticated-orcid":false,"given":"M.","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2018.06.060_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers10010024","article-title":"Contemporary management of localized resectable pancreatic cancer","volume":"10","author":"Kommalapati","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.jpba.2018.06.060_bib0010","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1002\/jcp.26183","article-title":"Efficacy of different chemotherapy regimens in treatment of advanced or metastatic pancreatic cancer: a network meta-analysis","volume":"233","author":"Zhang","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.jpba.2018.06.060_bib0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000479970","article-title":"Efficacy and safety of capecitabine, irinotecan, gemcitabine, and bevacizumab as second-line treatment in advanced biliary tract cancer: a phase II study","volume":"94","author":"Larsen","year":"2018","journal-title":"Oncology"},{"key":"10.1016\/j.jpba.2018.06.060_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-016-3003-0","article-title":"Pharmacokinetics and pharmacogenetics of gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective","volume":"78","author":"Ciccolini","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jpba.2018.06.060_bib0025","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/cmdc.201600070","article-title":"Cationic supramolecular vesicular aggregates for pulmonary tissue selective delivery in anticancer therapy","volume":"11","author":"Licciardi","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jpba.2018.06.060_bib0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biomaterials.2016.07.037","article-title":"PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma","volume":"105","author":"Gaudin","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jpba.2018.06.060_bib0035","first-page":"5423","article-title":"Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives","volume":"7","author":"Federico","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jpba.2018.06.060_bib0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00262744","article-title":"Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo","volume":"21","author":"Tsuruo","year":"1988","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jpba.2018.06.060_bib0045","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/CAD.0000000000000545","article-title":"Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer","volume":"28","author":"Leonard","year":"2017","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jpba.2018.06.060_bib0050","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/BF00689205","article-title":"Identification and kinetics of a beta-glucuronide metabolite of SN-38 in human plasma after administration of the camptothecin derivative irinotecan","volume":"36","author":"Rivory","year":"1995","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jpba.2018.06.060_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-017-2278-0","article-title":"Liposomal irinotecan accumulates in metastatic lesions, crosses the blood-tumor barrier (BTB), and prolongs survival in an experimental model of brain metastases of triple negative breast cancer","volume":"35","author":"Mohammad","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2018.06.060_bib0060","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjc.6603301","article-title":"A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer","volume":"95","author":"Stathopoulos","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jpba.2018.06.060_bib0065","first-page":"5149","article-title":"Phase I dose escalation study of gemcitabine plus Irinotecan in advanced solid tumors","volume":"29","author":"Dugan","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jpba.2018.06.060_bib0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.chroma.2015.09.075","article-title":"Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector","volume":"1419","author":"Locatelli","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2018.06.060_bib0075","first-page":"1500","article-title":"Method development and validation of gemcitabine and Irinotecan by RP-HPLC in pharmaceutical formulation","volume":"3","author":"Mangamma","year":"2012","journal-title":"Int. J. Chem. Anal. Sci."},{"key":"10.1016\/j.jpba.2018.06.060_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118194","article-title":"Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study","volume":"10","author":"Marangon","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2018.06.060_bib0085","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/bmc.3134","article-title":"A rapid, simple and reliable HPLC-triple quadrupole tandem mass spectrometer method for a simultaneous quantification of irinotecan and its active metabolite 7-ethyl-10-hydroxycamptothecin (SN38) in mouse plasma","volume":"28","author":"Ahn","year":"2014","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2018.06.060_bib0090","series-title":"Harmonised Tripartite Guideline: Validation of Analytical Procedures: Text and Methodology","author":"International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use","year":"2005"},{"key":"10.1016\/j.jpba.2018.06.060_bib0095","first-page":"59","article-title":"Development and validation of a rapid and simple reversed-phase HPLC method for the determination of gemcitabine in human plasma","volume":"6","author":"Vidal","year":"2014","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jpba.2018.06.060_bib0100","first-page":"3961","article-title":"Bioanalytical method development and validation of gemcitabine hydrochloride by RP-HPLC method","volume":"23","author":"Rajesh","year":"2011","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.jpba.2018.06.060_bib0105","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/862592","article-title":"Stability-indicating HPLC determination of gemcitabine in pharmaceutical formulations","volume":"2015","author":"Singh","year":"2015","journal-title":"Int. J. Anal. Chem."},{"key":"10.1016\/j.jpba.2018.06.060_bib0110","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1002\/jps.24638","article-title":"Preanalytical stability of gemcitabine and its metabolite 2\u2019, 2\u2019-difluoro-2\u2019-deoxyuridine in whole blood-assessed by liquid chromatography tandem mass spectrometry","volume":"104","author":"Bj\u00e5nes","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2018.06.060_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2012.07.033","article-title":"Liquid chromatography\u2013tandem mass spectrometry method for simultaneous determination of seven commonly used anticancer drugs in human plasma","volume":"906","author":"Zhou","year":"2012","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2018.06.060_bib0120","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jchromb.2016.10.045","article-title":"A fabric phase sorptive extraction-High performance liquid chromatography-photo diode array detection method for the determination of twelve azole antimicrobial drug residues in human plasma and urine","volume":"1040","author":"Locatelli","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2018.06.060_bib0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jchromb.2018.03.028","article-title":"Fabric phase sorptive extraction-high performance liquid chromatography-photo diode array detection method for simultaneous monitoring of three inflammatory bowel disease treatment drugs in whole blood, plasma and urine","volume":"1084","author":"Kabir","year":"2018","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2018.06.060_bib0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jchromb.2014.08.024","article-title":"Development and validation of an ultra-high performance LC-MS\/MS assay for intracellular SN-38 in human solid tumour cell lines: comparison with a validated HPLC-fluorescence method","volume":"969","author":"Ghazaly","year":"2014","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"issue":"5","key":"10.1016\/j.jpba.2018.06.060_bib0135","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.talanta.2011.08.034","article-title":"Analysis of anticancer drugs: a review","volume":"85","author":"Nussbaumer","year":"2011","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2018.06.060_bib0140","first-page":"2182","article-title":"Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)","volume":"7","author":"Mathijssen","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jpba.2018.06.060_bib0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00280-012-2017-5","article-title":"In vitro and in vivo studies of pharmacokinetics and antitumor efficacy of D07001-F4, an oral gemcitabine formulation","volume":"71","author":"Hao","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jpba.2018.06.060_bib0150","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0090-9556(24)15060-X","article-title":"Pharmacokinetic, metabolism, and excretion of irinotecan (CPT-11) following i.v. infusion of [14C]CPT-11 in cancer patients","volume":"28","author":"Slatter","year":"2000","journal-title":"Drug Metab. Dispos."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518307179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518307179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T13:23:12Z","timestamp":1751721792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708518307179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":30,"alternative-id":["S0731708518307179"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2018.06.060","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride in rat plasma by using high performance liquid chromatography-diode array detector","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2018.06.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}